HCWB
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
P/S and P/B metrics indicate the stock is fundamentally overpriced relative to its distressed assets.
- Price/Sales of 45.26 is exorbitant for a declining company
- Negative Price/Book ratio
- No Graham Number available due to negative earnings/equity
Growth rates are in a state of collapse, making future viability unlikely without a massive capital infusion.
- Revenue growth is crashing (-93.16% Q/Q)
- Operating margins are deeply negative
- Earnings surprises are consistently negative
Historical price action shows a total loss of investor confidence.
- 5-year price change of -99.9%
- 1-year price change of -96.3%
- Consistent earnings misses
The company is in a state of severe financial distress with critical liquidity shortages.
- Piotroski F-Score 1/9
- Current Ratio 0.11 (cannot cover short-term liabilities)
- Debt/Equity of 2.46 on a negative equity base
Dividend profile is non-existent.
- No dividend history
- Zero payout capacity
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for HCWB and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
HCWB
HCW Biologics Inc.
Primary
|
-99.9% | -99.4% | -96.3% | -91.0% | -30.6% | +36.0% |
|
HCTI
Healthcare Triangle, Inc.
Peer
|
-100.0% | -100.0% | -99.9% | -98.6% | -21.6% | -2.8% |
|
BDRX
Biodexa Pharmaceuticals Plc
Peer
|
-100.0% | -100.0% | -95.1% | -75.6% | -24.0% | -4.0% |
|
AKAN
Akanda Corp.
Peer
|
-100.0% | -100.0% | -96.4% | -95.4% | -13.6% | -6.7% |
|
ACON
Aclarion, Inc.
Peer
|
-100.0% | -100.0% | -82.0% | -56.9% | +22.9% | +1.8% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
HCWB
HCW Biologics Inc.
|
BEARISH | $2.45M | - | -% | -% | $0.36 | |
|
HCTI
Healthcare Triangle, Inc.
|
BEARISH | $2.77M | - | -183.0% | -48.8% | $2.4 | Compare |
|
BDRX
Biodexa Pharmaceuticals Plc
|
BEARISH | $1.8M | - | -61.8% | -% | $2.15 | Compare |
|
AKAN
Akanda Corp.
|
BEARISH | $1.73M | 0.01 | -60.9% | -266.3% | $0.82 | Compare |
|
ACON
Aclarion, Inc.
|
BEARISH | $3.51M | - | -97.7% | -% | $3.33 | Compare |
Past News Coverage
Recent headlines mentioning HCWB from our newsroom.